We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUN icon
51
Sunrun
RUN
$2.46B
$1.8M 0.12%
75,000
+37,500
+100% +$1M
MRNA icon
52
CALL
Moderna
MRNA
$23.6B
$1.8M 0.12%
10,000
-5,000
-33% -$818K
PEP icon
53
PepsiCo
PEP
$190B
$1.79M 0.12%
+9,931
New +$1.77M
AVEO
54
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.76M 0.12%
117,452
+3,291
+3% +$45.6K
NTAP icon
55
NetApp
NTAP
$37.2B
$1.74M 0.12%
+28,915
New +$1.92M
RGA icon
56
Reinsurance Group of America
RGA
$16.1B
$1.74M 0.12%
+12,215
New +$1.71M
AMZN icon
57
Amazon
AMZN
$2.96T
$1.73M 0.12%
20,636
-215,895
-91% -$21.3M
EA
58
DELISTED
Electronic Arts
EA
$1.7M 0.11%
+13,917
New +$1.75M
RPRX icon
59
Royalty Pharma
RPRX
$25.3B
$1.69M 0.11%
+42,786
New +$1.79M
EW icon
60
Edwards Lifesciences
EW
$51.7B
$1.67M 0.11%
22,400
+5,005
+29% +$386K
VEA icon
61
Vanguard FTSE Developed Markets ETF
VEA
$237B
$1.65M 0.11%
+39,243
New +$1.59M
KO icon
62
Coca-Cola
KO
$375B
$1.64M 0.11%
+25,828
New +$1.56M
BZUN
63
Baozun
BZUN
$172M
$1.63M 0.11%
308,299
+282,450
+1,093% +$1.35M
AAPL icon
64
Apple
AAPL
$4.57T
$1.63M 0.11%
+12,548
New +$1.79M
ESGR
65
DELISTED
Enstar Group
ESGR
$1.63M 0.11%
7,052
+2,412
+52% +$491K
KDP icon
66
Keurig Dr Pepper
KDP
$40.8B
$1.63M 0.11%
+45,661
New +$1.71M
OSG
67
Octave Specialty Group
OSG
$222M
$1.61M 0.11%
92,522
+26,208
+40% +$389K
TEN
68
Tsakos Energy Navigation Ltd
TEN
$1.18B
$1.61M 0.11%
95,189
-29,503
-24% -$516K
VFC icon
69
VF Corp
VFC
$5.89B
$1.58M 0.11%
57,072
+17,578
+45% +$517K
AGNC icon
70
AGNC Investment
AGNC
$12.9B
$1.57M 0.1%
151,910
+49,624
+49% +$453K
ON icon
71
ON Semiconductor
ON
$31.6B
$1.56M 0.1%
25,000
-126,325
-83% -$8.43M
CRM icon
72
Salesforce
CRM
$158B
$1.51M 0.1%
+11,385
New +$1.66M
INTC icon
73
Intel
INTC
$513B
$1.51M 0.1%
57,090
-29,989
-34% -$833K
XRAY icon
74
Dentsply Sirona
XRAY
$2.43B
$1.46M 0.1%
45,866
-8,194
-15% -$247K
SYY icon
75
Sysco
SYY
$40.3B
$1.44M 0.1%
18,784
+14,683
+358% +$1.19M

Similar funds

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.